Evidence map›Paper›PMID 41882229›Full record

ArticleScientific reports2026

N

Gulnaz Khan, Rizwana Sanaullah Waraich, Hurtamina Khan, Rifat Zubair Ahmed

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gulnaz KhanDepartment of Genetics, University of Karachi, Karachi, Pakistan. gullnaz.khann1@gmail.com.ORCID http://orcid.org/0009-0008-7858-1737
Rizwana Sanaullah WaraichBiomedical Research Center, Department of Biomedical and Biological Sciences, Sohail University, Karachi, Pakistan.
Hurtamina KhanDepartment of Head and Neck Surgery, Jinnah Postgraduate Medical Centre / Jinnah Sindh Medical University, Karachi, Pakistan.
Rifat Zubair AhmedDepartment of Genetics, University of Karachi, Karachi, Pakistan.ORCID http://orcid.org/0000-0002-5530-1383

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral cancer is a major public health concern in South Asia, particularly in Pakistan, India, and Bangladesh, largely due to the widespread use of smokeless tobacco (SLT) products. The World Health Organization (WHO) classifies SLT as a Group 1 carcinogen. These products contain glycotoxins, such as methylglyoxal (MGO) that is well-known to cause genotoxicity by reacting with DNA. One of the most stable MGO-derived DNA adducts is N2-(1-carboxyethyl)-2′-deoxyguanosine (CEdG), which has been reported to cause DNA damage and genetic instability. However, the role of CEdG in the pathogenesis of oral cancer remains unstudied, and the MGO content in various SLT has not been previously determined. To our knowledge, this study represents one of the first investigations into the abundance of CEdG in oral cancer and its association with chromatin organization, while also quantifying MGO levels in SLT. CEdG was detected using a semi-quantitative in situ immunofluorescence assay and correlated with chromatin computational morphometry to evaluate CEdG-associated alterations in chromatin organization. Using ELISA, we also assessed MGO levels in various SLT, revealing elevated concentrations in commonly used products such as gutka, naswar, and khaini. Our results demonstrated significantly higher levels of CEdG in cancerous nuclei and were strongly correlated with disorganized chromatin texture. Together, these findings suggest that exposure to MGO-rich SLT is associated with CEdG accumulation and subsequent chromatin disorganization, which may be relevant to tobacco-associated oral carcinogenesis.

Indexed as

Carcinoma, Squamous CellChromatinDeoxyguanosineMouth NeoplasmsBiomarkers, TumorDNA AdductsDNA DamageGlycosylationHumansPyruvaldehydeTobacco, SmokelessBiomarkers, TumorChromatinDeoxyguanosineDNA AdductsPyruvaldehydeChromatin organizationDNA damageGenetic instabilityN2-(1-carboxyethyl)-2′-deoxyguanosineOral cancerSmokeless tobacco

Identifiers

PMID41882229
PMCPMC13090384

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.